Pharmacogenomics is being implemented now and is already have an impact in the clinical setting and in healthcare. Employing a pharmacogenomics strategy with marketed drugs can mitigate risk by avoiding adverse events, allowing the identification of patients most likely to benefit from a drug, and thereby improving patient compliance and safety. Tangible benefits of pharmacogenomics and resequencing technologies will be presented, and the value of this approach will be demonstrated.
CHI鈥橲 Pharmacogenomics Now: Maximizing Benefits/Minimizing Risk
5 - 6 November 2008, Montreal, Quebec, Canada
Introduction
Venue
Hotel Omni Mont-Royal
Hotel Omni Mont-Royal, Montreal, Quebec, Canada
Useful links
Organised by
Cambridge Healthtech Institute
Contact information
Related events
Intelligent Clothing: Data-Driven Wearables For Human Performance
2 June 2026 17:00-18:00, United Kingdom
The 59th Annual International Meeting of the ESR Spectroscopy Group of the 欧美AV
13 April 2026 15:00 - 16 April 2026 23:00, Colchester, United Kingdom
What a chemist needs to know about Patents 2026
13 May 2026 09:00-17:40, London, United Kingdom
International Conference on Molluscan Shellfish Safety (ICMSS)
6 September 2026 14:00 - 11 September 2026 18:00, Exeter, United Kingdom
Search
Advertisement
Spotlight
Explore
Membership
